Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population.
Corren J, Szefler SJ, Sher E, Korenblat P, Soong W, Hanania NA, Berman G, Brusselle G, Zitnik R, Natalie CR, Sun L, Siu K, Wu WS, Lio P, Armstrong AW.
Corren J, et al. Among authors: siu k.
J Allergy Clin Immunol Pract. 2024 Feb 14:S2213-2198(24)00163-6. doi: 10.1016/j.jaip.2024.02.007. Online ahead of print.
J Allergy Clin Immunol Pract. 2024.
PMID: 38360213
Free article.